PESSOA, C. I. L.; PESSOA, Christian Inácio Luciano.
Résumé:
The increase in the elderly population worldwide has been projected, as well as the
incidence and prevalence of diseases related to this age group. The objective of this study
was to verify the effectiveness of cannabis therapy on dementia syndrome, showing
which factors contribute to the choice of treatment, exposing the repercussions of the use
of cannabis on the quality of life of patients, relating the role of the pharmacist in this
trajectory. For this, an integrative literature review was carried out in the electronic
databases PubMed, SciELO, LILACS, Science Direct, BVS and CAPES journals, using
publications between 2011 and 2021 and the following terms (keywords and delimiters)
and combinations of the same: Cannabis sativa, medical marijuana, Cannabis, senile
dementia, dementia syndrome, Alzheimer's disease, senescence, senility, pharmaceutical
care and clinical pharmaceutical, to answer the guiding questions. The sample consisted
of 10 studies that showed the effectiveness of the therapy and promising results on the
quality of life of the senile public, which is an auspicious choice of treatment, in addition
to the importance of the pharmacist in promoting this therapy. Studies like this help to
show the need to consider this treatment, which has been used for millennia by humanity,
but which, today, suffers from sociocultural remnants, as its consumption is linked to
recreational use. Finally, they awaken and optimize ideas for the development of new
valid and reliable instruments to support therapies for dementia syndrome.
